Literature DB >> 29955146

Clinicopathologic and molecular features in hairy cell leukemia-variant: single institutional experience.

Evgeniya A Angelova1, L Jeffrey Medeiros1, Wei Wang1, Tariq Muzzafar1, Xinyan Lu2, Joseph D Khoury1, Farhad Ravandi3, Keyur P Patel1, Zhihong Hu1, Rashmi Kanagal-Shamanna4.   

Abstract

Hairy cell leukemia-variant is rare. Only a small number of cases have been reported in the literature with little cytogenetic or molecular data available. In this study, we describe the clinicopathologic and genetic features of 23 patients with hairy cell leukemia-variant (16 men and 7 women) with a median age of 70 years. Most patients had splenomegaly (90%), leukocytosis (77%), and lymphocytosis (82%); no patients had monocytopenia. Histologically, the bone marrow biopsy specimens showed a mixed pattern of predominantly interstitial and lesser intrasinusoidal infiltration by leukemic cells. In bone marrow aspirate smears most cells had villous cytoplasmic features and a small nucleolus. We describe unusual sites of hairy cell leukemia-variant involvement in 4 patients, including brain, omentum, terminal ileum, and skin at the time of initial presentation. Immunophenotyping showed monotypic B-cells positive for pan B-cell antigens, CD11c, and CD103, and negative for CD25 and annexin A1. Conventional cytogenetic or fluorescence in situ hybridization analysis showed deletions of 17p13/TP53 and 11q22/ATM gene in 5/12 (42%) and 2/9 (22%) cases, respectively. Sequencing of the variable region of IGVH showed mutations (>2% deviation from germline) in 40% of the cases assessed. MAP2K1 mutation (p.C121S) was seen in 1 of 14 (7%) patients tested. No BRAF V600E mutations were detected. The patients were treated in a heterogeneous manner, but most often with therapies designed for classical hairy cell leukemia and the 5-year overall survival was 84%. In summary, hairy cell leukemia-variant exhibits a heterogeneous spectrum of clinical, morphologic, immunophenotypic, and genetic features that may overlap with classic hairy cell leukemia and other hairy cell-like B-cell neoplasms. A subset of patients can have an aggressive clinical course. In our experience MAP2K1 mutations are uncommon in this disease.

Entities:  

Mesh:

Year:  2018        PMID: 29955146     DOI: 10.1038/s41379-018-0093-8

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  13 in total

Review 1.  Immunohistochemistry Innovations for Diagnosis and Tissue-Based Biomarker Detection.

Authors:  Narittee Sukswai; Joseph D Khoury
Journal:  Curr Hematol Malig Rep       Date:  2019-10       Impact factor: 3.952

2.  BRAF in the cross-hairs.

Authors:  Mark B Geyer; Omar Abdel-Wahab; Martin S Tallman
Journal:  Expert Rev Hematol       Date:  2019-02-26       Impact factor: 2.929

3.  Purine nucleoside analogs plus rituximab are an effective treatment choice for hairy cell leukemia-variant.

Authors:  Yi Wang; Tingyu Wang; Ying Yu; Qi Wang; Yuting Yan; Ru Li; Qi Sun; Wenjie Xiong; Rui Lyu; Zhen Yu; Wei Liu; Weiwei Sui; Wenyang Huang; Huijun Wang; Chengwen Li; Jun Wang; Dehui Zou; Gang An; Jianxiang Wang; Lugui Qiu; Shuhua Yi
Journal:  Ann Hematol       Date:  2022-04-18       Impact factor: 3.673

Review 4.  Advances in the Treatment of Hairy Cell Leukemia Variant.

Authors:  Julie Tran; Charles Gaulin; Martin S Tallman
Journal:  Curr Treat Options Oncol       Date:  2022-02-18

Review 5.  The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms.

Authors:  Rita Alaggio; Catalina Amador; Ioannis Anagnostopoulos; Ayoma D Attygalle; Iguaracyra Barreto de Oliveira Araujo; Emilio Berti; Govind Bhagat; Anita Maria Borges; Daniel Boyer; Mariarita Calaminici; Amy Chadburn; John K C Chan; Wah Cheuk; Wee-Joo Chng; John K Choi; Shih-Sung Chuang; Sarah E Coupland; Magdalena Czader; Sandeep S Dave; Daphne de Jong; Ming-Qing Du; Kojo S Elenitoba-Johnson; Judith Ferry; Julia Geyer; Dita Gratzinger; Joan Guitart; Sumeet Gujral; Marian Harris; Christine J Harrison; Sylvia Hartmann; Andreas Hochhaus; Patty M Jansen; Kennosuke Karube; Werner Kempf; Joseph Khoury; Hiroshi Kimura; Wolfram Klapper; Alexandra E Kovach; Shaji Kumar; Alexander J Lazar; Stefano Lazzi; Lorenzo Leoncini; Nelson Leung; Vasiliki Leventaki; Xiao-Qiu Li; Megan S Lim; Wei-Ping Liu; Abner Louissaint; Andrea Marcogliese; L Jeffrey Medeiros; Michael Michal; Roberto N Miranda; Christina Mitteldorf; Santiago Montes-Moreno; William Morice; Valentina Nardi; Kikkeri N Naresh; Yasodha Natkunam; Siok-Bian Ng; Ilske Oschlies; German Ott; Marie Parrens; Melissa Pulitzer; S Vincent Rajkumar; Andrew C Rawstron; Karen Rech; Andreas Rosenwald; Jonathan Said; Clémentine Sarkozy; Shahin Sayed; Caner Saygin; Anna Schuh; William Sewell; Reiner Siebert; Aliyah R Sohani; Reuben Tooze; Alexandra Traverse-Glehen; Francisco Vega; Beatrice Vergier; Ashutosh D Wechalekar; Brent Wood; Luc Xerri; Wenbin Xiao
Journal:  Leukemia       Date:  2022-06-22       Impact factor: 12.883

Review 6.  Hairy Cell Leukaemia.

Authors:  Matthew Cross; Claire Dearden
Journal:  Curr Oncol Rep       Date:  2020-04-16       Impact factor: 5.075

7.  Long-term follow-up after rituximab plus bendamustine in a patient with relapsed or refractory hairy cell leukemia variant: A case report.

Authors:  Naoto Imoto; Daisuke Koyama; Isamu Sugiura; Shingo Kurahashi
Journal:  Medicine (Baltimore)       Date:  2021-02-05       Impact factor: 1.817

Review 8.  Current and Emerging Therapeutic Options for Hairy Cell Leukemia Variant.

Authors:  Qiuying Liu; Nicholas Harris; Narendranath Epperla; Leslie A Andritsos
Journal:  Onco Targets Ther       Date:  2021-03-09       Impact factor: 4.147

9.  Immunophenotypic Analysis of Hairy Cell Leukemia (HCL) and Hairy Cell Leukemia-like (HCL-like) Disorders.

Authors:  Elsa Maitre; Edouard Cornet; Véronique Salaün; Pauline Kerneves; Stéphane Chèze; Yohan Repesse; Gandhi Damaj; Xavier Troussard
Journal:  Cancers (Basel)       Date:  2022-02-18       Impact factor: 6.639

10.  Concurrent chronic lymphocytic leukemia/small lymphocytic lymphoma and hairy cell leukemia: clinical, pathologic and molecular features.

Authors:  Ifeyinwa Emmanuela Obiorah; Ivo M B Francischetti; Hao-Wei Wang; Inhye E Ahn; Weixin Wang; Mark Raffeld; Robert J Kreitman; Adrian Wiestner; Katherine R Calvo
Journal:  Leuk Lymphoma       Date:  2020-08-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.